Clinical Trial Update: Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating varenicline to reduce falls in patients with hypocholinergic Parkinson disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Vikas Kotagal | Conditions: Parkinson Disease | Phase 2 | Status: RECRUITING